vvd-101
Small moleculeexperimental
Clinical trial activity
1 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jul 1, 2014 (NCT02176655)
Timeline
2010s
- Jan 1, 2014
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- vvd-101
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02176655 | Phase 2 | Jul 1, 2014 | Alder Biopharmaceuticals, Allergan PLC (2015), Clinvest, Vivid Pharma Inc. |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Alder Biopharmaceuticals | For profit | 1 | 0 | 1 | 2014 |
| Allergan PLC (2015) | For profit | 1 | 1 | 1 | 2014 |
| Clinvest | For profit | 1 | 0 | 1 | 2014 |
| Vivid Pharma Inc. | For profit | 1 | 0 | 1 | 2014 |
4 organizations
Page 1 / 1